1AD 0.00% 1.7¢ adalta limited

Ann: SYNBV MoU Webinar presentation, page-48

  1. 12,670 Posts.
    lightbulb Created with Sketch. 2578
    what a joke

    Back to $15m MC and heading into Phase 2 trials

    On top of that they are working on multiple opportunities and have also signed an MOU with SYNThesis BioVentures.

    NYR up 11% on nothing and back to $20m MC+ and a pre-clinical trials still.....lol
 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.